Cargando…

Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment

Aims: To investigate the incidence of cardiac implantable electronic devices (CIED) malfunction with radiotherapy (RT) treatment and assess predictors of CIED malfunction. Methods: A 6-year retrospective analysis of patients who underwent RT with CIED identified through the radiation oncology electr...

Descripción completa

Detalles Bibliográficos
Autores principales: Azraai, Meor, Miura, Daisuke, Lin, Yuan-Hong, Rodrigues, Thalys Sampaio, Nadurata, Voltaire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654752/
https://www.ncbi.nlm.nih.gov/pubmed/36362559
http://dx.doi.org/10.3390/jcm11216329
_version_ 1784829010811813888
author Azraai, Meor
Miura, Daisuke
Lin, Yuan-Hong
Rodrigues, Thalys Sampaio
Nadurata, Voltaire
author_facet Azraai, Meor
Miura, Daisuke
Lin, Yuan-Hong
Rodrigues, Thalys Sampaio
Nadurata, Voltaire
author_sort Azraai, Meor
collection PubMed
description Aims: To investigate the incidence of cardiac implantable electronic devices (CIED) malfunction with radiotherapy (RT) treatment and assess predictors of CIED malfunction. Methods: A 6-year retrospective analysis of patients who underwent RT with CIED identified through the radiation oncology electronic database. Clinical, RT (cumulative dose, dose per fraction, beam energy, beam energy dose, and anatomical area of RT) and CIED details (type, manufacturer, and device malfunction) were collected from electronic medical records. Results: We identified 441 patients with CIED who underwent RT. CIED encountered a permanent pacemaker (PPM) (78%), cardiac resynchronization therapy—pacing (CRT-P) (2%), an implantable cardioverter defibrillator (ICD) (10%), and a CRT-defibrillator (CRT-D) (10%). The mean cumulative dose of RT was 36 gray (Gy) (IQR 1.8–80 Gy) and the most common beam energy used was photon ≥10 megavolt (MV) with a median dose of 7 MV (IQR 5–18 MV). We further identified 17 patients who had CIED malfunction with RT. This group had a higher cumulative RT dose of 42.5 Gy (20–77 Gy) and a photon dose of 14 MV (12–18 MV). None of the malfunctions resulted in clinical symptoms. Using logistic regression, the predictors of CIED malfunction were photon beam energy use ≥10 MV (OR 5.73; 95% CI, 1.58–10.76), anatomical location of RT above the diaphragm (OR 5.2, 95% CI, 1.82–15.2), and having a CIED from the ICD group (OR 4.6, 95% CI, 0.75–10.2). Conclusion: Clinicians should be aware of predictors of CIED malfunction with RT to ensure the safety of patients.
format Online
Article
Text
id pubmed-9654752
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96547522022-11-15 Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment Azraai, Meor Miura, Daisuke Lin, Yuan-Hong Rodrigues, Thalys Sampaio Nadurata, Voltaire J Clin Med Article Aims: To investigate the incidence of cardiac implantable electronic devices (CIED) malfunction with radiotherapy (RT) treatment and assess predictors of CIED malfunction. Methods: A 6-year retrospective analysis of patients who underwent RT with CIED identified through the radiation oncology electronic database. Clinical, RT (cumulative dose, dose per fraction, beam energy, beam energy dose, and anatomical area of RT) and CIED details (type, manufacturer, and device malfunction) were collected from electronic medical records. Results: We identified 441 patients with CIED who underwent RT. CIED encountered a permanent pacemaker (PPM) (78%), cardiac resynchronization therapy—pacing (CRT-P) (2%), an implantable cardioverter defibrillator (ICD) (10%), and a CRT-defibrillator (CRT-D) (10%). The mean cumulative dose of RT was 36 gray (Gy) (IQR 1.8–80 Gy) and the most common beam energy used was photon ≥10 megavolt (MV) with a median dose of 7 MV (IQR 5–18 MV). We further identified 17 patients who had CIED malfunction with RT. This group had a higher cumulative RT dose of 42.5 Gy (20–77 Gy) and a photon dose of 14 MV (12–18 MV). None of the malfunctions resulted in clinical symptoms. Using logistic regression, the predictors of CIED malfunction were photon beam energy use ≥10 MV (OR 5.73; 95% CI, 1.58–10.76), anatomical location of RT above the diaphragm (OR 5.2, 95% CI, 1.82–15.2), and having a CIED from the ICD group (OR 4.6, 95% CI, 0.75–10.2). Conclusion: Clinicians should be aware of predictors of CIED malfunction with RT to ensure the safety of patients. MDPI 2022-10-27 /pmc/articles/PMC9654752/ /pubmed/36362559 http://dx.doi.org/10.3390/jcm11216329 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Azraai, Meor
Miura, Daisuke
Lin, Yuan-Hong
Rodrigues, Thalys Sampaio
Nadurata, Voltaire
Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment
title Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment
title_full Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment
title_fullStr Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment
title_full_unstemmed Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment
title_short Incidence and Predictors of Cardiac Implantable Electronic Devices Malfunction with Radiotherapy Treatment
title_sort incidence and predictors of cardiac implantable electronic devices malfunction with radiotherapy treatment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654752/
https://www.ncbi.nlm.nih.gov/pubmed/36362559
http://dx.doi.org/10.3390/jcm11216329
work_keys_str_mv AT azraaimeor incidenceandpredictorsofcardiacimplantableelectronicdevicesmalfunctionwithradiotherapytreatment
AT miuradaisuke incidenceandpredictorsofcardiacimplantableelectronicdevicesmalfunctionwithradiotherapytreatment
AT linyuanhong incidenceandpredictorsofcardiacimplantableelectronicdevicesmalfunctionwithradiotherapytreatment
AT rodriguesthalyssampaio incidenceandpredictorsofcardiacimplantableelectronicdevicesmalfunctionwithradiotherapytreatment
AT naduratavoltaire incidenceandpredictorsofcardiacimplantableelectronicdevicesmalfunctionwithradiotherapytreatment